TETRALOGIC PHARMACEUTICALS C - COM (TLOG)

CUSIP: 88165U109

Q4 2014 13F Holders as of 31 Dec 2014

Type / Class
Equity / COM
Total 13F shares
6,342,646
Share change
-109,688
Total reported value
$30,597,000
Price per share
$4.82
Number of holders
31
Value change
-$250,195
Number of buys
14
Number of sells
12

Quarterly Holders Quick Answers

What is CUSIP 88165U109?
CUSIP 88165U109 identifies TLOG - TETRALOGIC PHARMACEUTICALS C - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of TETRALOGIC PHARMACEUTICALS C - COM (TLOG) as of Q4 2014

As of 31 Dec 2014, TETRALOGIC PHARMACEUTICALS C - COM (TLOG) was held by 31 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 6,342,646 shares. The largest 10 holders included Clarus Ventures, LLC, KINGDON CAPITAL MANAGEMENT, L.L.C., First Washington CORP, EMERALD ADVISERS INC/PA, WELLINGTON MANAGEMENT GROUP LLP, First Eagle Investment Management, LLC, VANGUARD GROUP INC, Point72 Asset Management, L.P., PURA VIDA INVESTMENTS, LLC, and Alyeska Investment Group, L.P.. This page lists 31 institutional shareholders reporting positions in this security for the Q4 2014 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.